Dr Reddy's launch new generic drug

The drug is a therapeutic equivalent generic version of MIRAPEX ER (pramipexole dihydrochloride) Extended-Release Tablets

Dr Reddy's Laboratories has announced that it has launched PRAMIPEXOLE dihydrochloride extended-release tablets, in the US market, following the approval by the United States Food and Drug Administration (US FDA). Pramipexole is used for treating the signs and symptoms of Parkinson disease.

The drug is a therapeutic equivalent generic version of MIRAPEX ER (pramipexole dihydrochloride) extended-release tablets. Dr Reddy's PRAMIPEXOLE dihydrochloride extended-release tablets are available in 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in bottle count sizes of 30.

The MIRAPEX ER brand and generic had the US sales of approximately $48.3 Million MAT for the most recent twelve months ending in June 2015, according to IMS Health.

Dr Reddy's PRAMIPEXOLE dihydrochloride extended-release tablets are available in 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in bottle count sizes of 30.